Evidence map›Paper›PMID 24383555›Full record

ReviewAntioxidants & redox signaling2014

Stem cells, redox signaling, and stem cell aging.

Raymond Liang, Saghi Ghaffari

Abstract readReview
In one paragraph

Review in Antioxidants & redox signaling, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 109 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Periplakin Attenuates Liver Fibrosis via Reprogramming CD44Cellular and molecular gastroenterology and hepatology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Cell cycle (Georgetown, Tex.) · 2022
    Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Mitochondrial Contributions to Hematopoietic Stem Cell Aging.International journal of molecular sciences · 2021
    Review
  17. Article
  18. Review
  19. Article
  20. Stem Cell Aging and Regenerative Medicine.Advances in experimental medicine and biology · 2021
    Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Raymond Liang1 Department of Developmental & Regenerative Biology, Icahn School of Medicine at Mount Sinai , New York, New York.
Saghi Ghaffari
Icahn School of Medicine at Mount Sinai · US

Funding

AKT Signaling and Oxidative Stress Regulation of ErythropoiesisR01DK077174 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GHAFFARI, SAGHI · 2009 to 2013
$1.9M
TRAINING PROGRAM IN CELLULAR AND MOLECULAR BIOLOGYT32GM008553 · NIGMS · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI MLODZIK, MAREK · 1995 to 2012
$1.6M
NIDDK NIH HHS R01 DK077174NIGMS NIH HHS GM008553PHS HHS R01 RHL116365A
6 · The paper itself

Abstract

significanceFunctional stem cell decline has been postulated to result in loss of maintenance of tissue homeostasis leading to organismal decline and diseases of aging. RECENT ADVANCES: Recent findings implicate redox metabolism in the control of stem cell pool and stem cell aging. Although reactive oxygen species (ROS) are better known for their damaging properties to DNA, proteins and lipids, recent findings suggest that ROS may also be an integral physiological mediator of cellular signaling in primary cells. CRITICAL ISSUES: Here we review recent published work on major signaling pathways and transcription factors that are regulated by ROS and mediate ROS regulation of stem cell fate. We will specifically focus on how alterations in this regulation may be implicated in disease and particularly in diseases of stem cell aging. In general, based on the work described here we propose a model in which ROS function as stem cell rheostat. FUTURE DIRECTIONS: Future work in elucidating how ROS control stem cell cycling, apoptotic machinery, and lineage determination should shed light on mechanisms whereby ROS may control stem cell aging.

Indexed as

Cellular SenescenceSignal TransductionHumansOxidation-ReductionStem Cells

Identifiers

PMID24383555
PMCPMC3967383
OpenAlexW1995691676

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.